Showing results (511-520 of 709) with videos related to

Sort By:
Pageof 71
Biochemistry|February 7, 1989
Epitope mapping employing antibodies raised against short synthetic peptides: a study of the nicotinic acetylcholine receptorA Maelicke, R Plümer-Wilk, G Fels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 10, 2013
Predictors of treatment failure for pneumatic retinopexyDan B Rootman, Shelly Luu, Stephen M Conti, et al.
The Journal of Biological Chemistry|April 8, 1994
Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor alpha-polypeptideB Schröder, S Reinhardt-Maelicke, A Schrattenholz, et al.
La Ricerca in Clinica E in Laboratorio|April 1, 1989
Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assayF Marongiu, A M Mamusa, G Mameli, et al.
The Journal of Clinical Endocrinology and Metabolism|December 15, 2005
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes StudyF Cavalot, A Petrelli, M Traversa, et al.
Cell Death & Disease|June 19, 2015
Tet3 mediates stable glucocorticoid-induced alterations in DNA methylation and Dnmt3a/Dkk1 expression in neural progenitorsR Bose, S Spulber, P Kilian, et al.
Placenta|March 23, 2004
Impact of trisomy 21 on human trophoblast behaviour and hormonal functionG Pidoux, J Guibourdenche, J-L Frendo, et al.
La Radiologia Medica|November 1, 1991
[Interventional radiology of the digestive system]G Simonetti, S Profili, G B Meloni, et al.
Pharmacoepidemiology and Drug Safety|May 4, 2012
Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisoryStacie B Dusetzina, Alisa B Busch, Rena M Conti, et al.
Pageof 71